Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency-Reference-Cited by-同舟云学术

Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency

Published:2009-01-29 Issue:5 Volume:360 Page:447-458
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Aiuti Alessandro,Cattaneo Federica,Galimberti Stefania,Benninghoff Ulrike,Cassani Barbara,Callegaro Luciano,Scaramuzza Samantha,Andolfi Grazia,Mirolo Massimiliano,Brigida Immacolata,Tabucchi Antonella,Carlucci Filippo,Eibl Martha,Aker Memet,Slavin Shimon,Al-Mousa Hamoud,Al Ghonaium Abdulaziz,Ferster Alina,Duppenthaler Andrea,Notarangelo Luigi,Wintergerst Uwe,Buckley Rebecca H.,Bregni Marco,Marktel Sarah,Valsecchi Maria Grazia,Rossi Paolo,Ciceri Fabio,Miniero Roberto,Bordignon Claudio,Roncarolo Maria-Grazia

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa0805817

Cited by 875 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of the Conditioning Regimen for Autologous and Ex Vivo Genetically Modified Hematopoietic Stem Cell-based Therapies: Recommendations from the ISCT Stem Cell Engineering Committee;Cytotherapy;2024-09

2. Adeno-Associated Virus Vectors—a Target of Cellular and Humoral Immunity—are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies;Human Gene Therapy;2024-08-28

3. Gene therapy clinical trials worldwide to 2023—an update;The Journal of Gene Medicine;2024-08

4. Gene therapy in pediatrics – Clinical studies and approved drugs (as of 2023);Life Sciences;2024-07

5. Embryo and fetal gene editing: Technical challenges and progress toward clinical applications;Molecular Therapy - Methods & Clinical Development;2024-06